Position in BMY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,046,835
-$124,677 QoQ
Shares Held
35,523
-0.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#829
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COURIER CAPITAL LLC holds $42,194,870 across 11 Drug Manufacturers - General names. BMY ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,486 | $16,377,509 | |
| 2 | MRK |
Merck & Co., Inc.
|
53,603 | $6,887,985 | |
| 3 | LLY |
ELI LILLY & Co
|
4,669 | $5,600,139 | |
| 4 | AMGN |
Amgen Inc
|
12,257 | $4,438,504 | |
| 5 | ABBV |
AbbVie Inc.
|
15,875 | $3,994,785 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
35,523 | $2,046,835 | |
| 7 | AZN |
Astrazeneca PLC
|
5,104 | $967,820 | |
| 8 | PFE |
Pfizer Inc
|
39,040 | $940,083 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,046,835 | 35,523 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,171,512 | 35,804 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,949,823 | 36,148 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,679,884 | 37,248 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,775,036 | 38,346 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,434,049 | 39,909 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,174,109 | 38,439 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,227,200 | 43,046 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,828,150 | 44,020 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,420,284 | 44,630 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,386,582 | 46,513 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $2,741,925 | 47,242 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $3,194,622 | 49,955 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,939,991 | 42,418 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $3,146,733 | 43,735 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $3,133,718 | 44,081 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $3,189,494 | 41,422 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $2,887,752 | 39,542 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,689,903 | 43,142 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,515,375 | 42,511 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $2,838,981 | 42,487 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $2,617,811 | 41,467 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,510,664 | 40,475 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,388,026 | 39,609 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,338,417 | 39,769 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $2,290,579 | 41,094 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||